Dr. Derek van Amerongen introduces a panel discussing hepatic encephalopathy (HE), noting that 30-40% of cirrhotic patients develop overt HE. Dr. Arun Jesudian explains that hepatic encephalopathy (HE ...

ACG published its first complete guideline on the diagnosis and management of hepatic encephalopathy, with practical tools for clinicians and interventions to help ease the negative impact on both ...

"Post-TIPS HE [hepatic encephalopathy] may reflect the patients' overall vulnerability leading to an increased risk for complications and thus explaining the overall poorer prognosis of these patients ...

The study results were recently published in Hepatology Communications. Hepatic encephalopathy is the loss of brain function that occurs in people with severe liver disease. The condition is ...

Salix Pharmaceuticals, the gastroenterology unit of Bausch Health, is linking up with actor Bellamy Young to raise awareness about hepatic encephalopathy, a brain disease associated with advanced ...

Please provide your email address to receive an email when new articles are posted on . PHILADELPHIA — Hepatologists and gastroenterologists must be internal medicine physicians, not just specialists, ...

Abstract Background Hepatic encephalopathy is a chronically debilitating complication of hepatic cirrhosis. The efficacy of rifaximin, a minimally absorbed antibiotic, is well documented in the ...

Bausch Health’s gastroenterology business arm, Salix, is using its new spot for Xifaxan to educate patients with cirrhosis of the liver about the risk of overt hepatic encephalopathy (OHE). Up to 80% ...

Research lays the groundwork for an app that may one day be able to listen to the patient read a paragraph and detect hepatic encephalopathy from their speech. Research from the University of Michigan ...

The panel emphasizes the need for alignment and collaboration to enhance outcomes in hepatic encephalopathy (HE), stressing the importance of implementation science, APP education, and proactive ...

The performance of neurodegenerative biomarkers-neurofilament light chain (NfL), glial fibrillary acidic protein (GFAP), tau, and ubiquitin carboxy-terminal hydrolase L1 (UCHL1)-in diagnosing minimal ...